NDAINJECTIONINJECTABLE
Approved
Dec 1958
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BICILLIN L-A (penicillin g benzathine) by Thayer Medical is mechanism of action penicillin g exerts a bactericidal action against penicillin-susceptible microorganisms during the stage of active multiplication. First approved in 1958.
Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BICILLIN L-A is a long-acting intramuscular injection of penicillin G benzathine, a beta-lactam antibiotic approved in 1958. It treats penicillin-susceptible bacterial infections by inhibiting cell-wall peptidoglycan biosynthesis, rendering bacteria osmotically unstable. The benzathine salt formulation provides sustained release, enabling less frequent dosing compared to aqueous penicillin.
$4MPart D
LOE ApproachingDeclining
Near end-of-life product with minimal spending; team likely focused on maintenance rather than growth investment.
Mechanism of Action
Mechanism of Action Penicillin G exerts a bactericidal action against penicillin-susceptible microorganisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell-wall peptidoglycan, rendering the cell wall osmotically unstable.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on BICILLIN L-A offers limited career growth due to its LOE-approaching status and minimal linked job opportunities. This role suits professionals focused on managing mature products, optimizing pricing and reimbursement in niche markets, or supporting legacy product portfolios at smaller specialty pharma companies.
Product Manager
Worked on BICILLIN L-A at Thayer Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.